With the controversial approval of Alzheimer’s drug Aducanumab in the United States, we speak to neurologist and medicinal chemist Dr. Donald Weaver, to break down the science, sift through the hype, and help us understand why it’s so difficult to diagnose and treat a disease that affects more than 55 million people worldwide. As the co-Director of Krembil Brain Institute  and with thirty years of experience as both a doctor and a scientist, Dr. Weaver is not convinced this new drug is the answer. But he says progress is being made and there’s plenty of reason for hope. Plus, we go on an inspiring journey with Patty Kim, who is caring for her mother with Alzheimer’s and there are tangible tips on how to reduce your chances of getting Alzheimer’s or dementia.Featuring: Dr. Weaver, Neurologist, Medicinal Chemist, and the co-Director of KBISpecial thanks to Patty Kim for sharing her story.To hear more from Patty, listen to her full story here:  https://www.uhn.ca/Krembil/Complex-Brain-Podcast/Additional Resources:Krembil Brain Institute Dr. Donald Weaver’s lab websiteThe Alzheimer Society of CanadaOntario Caregiver Organization Toronto Rehabilitation Institute’s Specialized Dementia Unit Toronto Dementia Research AllianceVideos:Risk Factors for Alzheimer’s and DementiaLiving with Dementia: A Caregiver’s PerspectiveThe Future of Alzheimer’s SymposiumThe Krembil Brain Institute, part of University Health Network, in Toronto, is home to one of the world's largest and most comprehensive teams of physicians and scientists uniquely working hand-in-hand to prevent and confront problems of the brain and spine, such as Parkinson's, Alzheimer's, epilepsy, stroke, spinal cord injury, chronic pain, brain cancer or concussion, in their lifetime. Through state-of-the-art patient care and advanced research, we are working relentlessly toward finding new treatments and cures.Do you want to know more about the Krembil Brain Institute at UHN? Visit us at: uhn.ca/krembilTo get in touch, email us at krembil@uhnresearch.ca or message us on social media:Instagram - @krembilresearchTwitter - @KBI_UHNFacebook - https://www.facebook.com/KrembilBrainInstituteThanks for listening!